What is the LDL:ApoB Ratio?
The LDL:ApoB ratio compares the amount of “bad” LDL cholesterol in your blood to the total number of particles carrying it.
- LDL cholesterol: Measures how much LDL cholesterol is being carried inside LDL particles.
- Apolipoprotein B (ApoB): Measures how many artery-clogging particles are present. Every LDL particle carries exactly one ApoB molecule, so ApoB is essentially a count of how many of these particles are circulating.
Think of it like shipping boxes. LDL cholesterol is the total weight of cargo being shipped, while ApoB is the number of delivery trucks on the road. A high ratio means fewer trucks are each carrying a heavy load. A low ratio means many trucks are out, each carrying less — and those smaller, more numerous trucks are the ones more likely to squeeze into artery walls and contribute to plaque buildup.
A low LDL:ApoB ratio indicates that LDL cholesterol is spread across many smaller, denser particles — a pattern associated with greater cardiovascular risk, even when total LDL appears normal.
A high LDL:ApoB ratio suggests cholesterol is concentrated in fewer, larger particles, which are generally considered less harmful.
It is important to look at this ratio alongside the rest of your lipid panel. Even if the ratio looks favorable, high LDL cholesterol or high ApoB levels can still increase cardiovascular risk.
Why Does LDL to ApoB Ratio Matter
- Helps reveal cardiovascular risk that LDL cholesterol alone may miss
- Shows whether cholesterol is packed into a few particles or spread across many particles (more particles increase the chances that cholesterol can enter artery walls and form plaque)
Book your test now
Test 50+ biomarkers & meet with a longevity physician, uncover the root cause of symptoms
- HSA/FSA eligible
- Physician reviewed
- 100% satisfaction guaranteed
How to Interpret LDL to ApoB Ratio
(Ranges may vary slightly by lab)
Standard reference ranges represent the middle 95% of healthy individuals but don’t necessarily reflect levels associated with longevity. Optimal ranges are derived from clinical guidelines, peer-reviewed research, and real-world outcomes data, with an emphasis on levels associated with peak functioning and reduced disease risk.
Benefits of Optimizing LDL to ApoB Ratio
- Fewer artery-clogging particles circulating in the bloodstream that can contribute to plaque buildup
- Improved cardiovascular health
- Reduced risk of atherosclerosis, heart attack, and stroke
Know your numbers. Own your health.
50+ biomarkers that reflect how your body is functioning — and where there’s room to optimize. Plus a clinical consult and personalized treatment plan. All for $65.
Low LDL:ApoB Ratio
Low LDL:ApoB ratios suggest that cholesterol is spread across a larger number of particles, which is often linked to smaller LDL particles and a higher risk of plaque buildup in the arteries. When symptoms occur, they typically reflect underlying cardiovascular or metabolic conditions rather than the ratio itself.
Symptoms:
- Often asymptomatic
Causes:
- Insulin resistance
- Type 2 diabetes
- Obesity
- High triglycerides
- Non-alcoholic fatty liver disease
- Hyperthyroidism
- Chronic inflammation
- Smoking
Healthspan Impacts:
- Increased long-term risk of heart attack, stroke, and peripheral artery disease1
High LDL:ApoB Ratio
Higher LDL:ApoB ratios are generally considered favorable when ApoB, LDL cholesterol, and triglycerides are also within healthy ranges. However, if LDL cholesterol and ApoB levels are both high, overall cardiovascular risk may still be elevated. When symptoms occur, they usually reflect underlying cardiovascular or metabolic disease rather than the ratio itself.
Symptoms:
- Typically asymptomatic
Causes:
- Hypothyroidism
- Insulin resistance
- Kidney disorder
- Obesity
- Smoking
- High saturated fat intake
Healthspan Impacts:
How Hone Treats Out of Range LDL to ApoB Ratio
Your Hone physician will evaluate the LDL:ApoB ratio alongside ApoB, LDL cholesterol, triglycerides, HDL cholesterol, and other cardiometabolic markers to understand what may be driving your lipid pattern. Because this ratio reflects how cholesterol is distributed across lipoprotein particles, treatment focuses on addressing the underlying metabolic and cardiovascular risk factors rather than the ratio itself.
- Statins (e.g. Rosuvastatin) – to lower LDL cholesterol and ApoB
- Cholesterol absorption inhibitors (e.g. Ezetimibe) – to reduce ApoB by lowering LDL
- Metformin – to lower ApoB in people with insulin resistance
- GLP-1 receptor agonists — to improve glucose regulation and improve insulin sensitivity
- Estradiol — to lower LDL cholesterol in women experiencing symptoms of menopause
- PCSK9 inhibition* – to significantly lower LDL cholesterol and ApoB
*Your Hone Physician does not prescribe these treatments but will recommend further evaluation and help coordinate care with your primary care provider when medical treatment is indicated.
- Participate in regular, moderate-intensity exercise
- Eat a whole-food diet rich in vegetables, fiber (beans, quinoa), nuts, seeds, legumes, and healthy fats (olive oils, nuts)
- Reduce alcohol consumption
- Give up smoking
- Maintain a healthy weight
Xiao L, et al.(2023). The LDL-C/ApoB ratio predicts cardiovascular and all-cause mortality in the general population. Lipids Health Dis.
↑Oliveira-Gomes, D. D., et al. (2024). APOLIPOPROTEIN B: Bridging the gap between evidence and clinical practice. Circulation.
↑Silbernagel, G., et al. (2022). The LDL Apolipoprotein B-to-LDL Cholesterol Ratio: Association with Cardiovascular Mortality and a Biomarker of Small, Dense LDLs. Biomedicines.
↑Koppen, L. M., et al. (2017). Efficacy of Berberine Alone and in Combination for the Treatment of Hyperlipidemia: A Systematic Review. Journal of Evidence-Based Complementary & Alternative Medicine.
↑Jovanovski, E., et al. (2018). Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B: A systematic review and meta-analysis of randomized controlled trials. The American Journal of Clinical Nutrition.
↑Barkas, F., et al. (2023). Plant Sterols and Plant Stanols in Cholesterol Management and Cardiovascular Prevention. Nutrients.
↑
Reviewed for Accuracy by Our Medical Review Board
This biomarker information has been reviewed by a member of Hone’s medical review board. As part of the medical review team, physicians fact-check this content against the latest research and their own experience treating their patients.
Ashley Winter, M.D., is a board-certified urogynecologist trained at Weill Cornell and Cleveland Clinic. She specializes in female and male sexual dysfunction, urinary issues, genital pain, and hormone therapy.
James Staheli, D.O., is the Medical Director for Broad Health, Hone Health’s affiliated medical practice and a family medicine doctor in Atlanta, Georgia.
